TCG Crossover Management »

Editas Medicine shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $36M 11M 3.24

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Comm (ABVX)
Tango Therapeutics Comm (TNGX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Immunovant Comm (IMVT)
Spyre Therapeutics Comm (SYRE)
Dianthus Therapeutics Comm (DNTH)
Mirum Pharmaceuticals Comm (MIRM)
Zai Lab Ltd- Adrs (ZLAB)
Amylyx Pharmaceuticals Comm (AMLX)
Monte Rosa Therapeutics Comm (GLUE)
Biocryst Pharmaceuticals Comm (BCRX)
Vor Biopharma Comm (VOR)
Tyra Biosciences Comm (TYRA)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Editas Medicine

TCG Crossover Management
BlackRock
ADAR1 Capital Management
RA Capital Management
Commodore Capital
Vanguard Capital Management
Paradigm Biocapital Advisors
Opaleye Management
Vanguard Portfolio Management
Woodline Partners
Vivo Capital
Goldman Sachs Group
Geode Capital Management
Renaissance Technologies
Logos Global Management

View all funds holding Editas Medicine